BKYI vs. VFORX

In the year-to-date period, BKYI achieves a -29.24% return, which is significantly lower than VFORX's 4.00% return. Over the past 10 years, BKYI has underperformed VFORX with an annualized return of -43.81%, while VFORX has yielded a comparatively higher 6.08% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for BIO-key International, Inc. (BKYI) and Vanguard Target Retirement 2040 Fund (VFORX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BKYI Sharpe Ratio is -0.20, which is lower than the VFORX Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of BKYI and VFORX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BKYI has not paid dividends to shareholders, while VFORX's dividend yield for the trailing twelve months is around 2.35%.

The maximum BKYI drawdown since its inception was -100.00%, which is greater than VFORX's maximum drawdown of -51.63%. Use the drawdown chart below to compare losses from any high point for BKYI and VFORX. For additional features, visit the drawdowns tool.

BIO-key International, Inc. (BKYI) has a higher volatility of 27.15% compared to Vanguard Target Retirement 2040 Fund (VFORX) at 2.37%. This indicates that BKYI's price experiences larger fluctuations and is considered to be riskier than VFORX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.